
Bremelanotide — a synthetic cyclic melanocortin agonist researched for sexual-arousal and MC3R/MC4R signalling.
Purity
99%+
CAS Number
189691-06-3
Status
In Stock
Dispatch
Same-Day (before 2pm)
Select Size
£199.99
Research verification required. All orders are reviewed before dispatch. You will receive an email confirmation and a WhatsApp or phone call within 60 minutes to verify your research purpose.
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide analogue of α-MSH that acts as a non-selective melanocortin receptor agonist with affinity for MC1R, MC3R and MC4R. Laboratory research has investigated its activity at central melanocortin receptors and its association with arousal-related neural pathways in animal models. Supplied as a lyophilised powder for in vitro research use only.
| Compound Name | PT-141 |
| Category | Sexual Health |
| CAS Number | 189691-06-3 |
| Molecular Weight | 1025.18 g/mol |
| Molecular Formula | C₅₀H₆₈N₁₄O₁₀ |
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Purity | ≥99%+ (HPLC) |
| Form | Lyophilised powder |
| Storage | Store lyophilised at -20°C. Protect from light. Reconstituted: aliquot and store at -80°C. Use within 30 days of reconstitution. |
| Reconstitution | Reconstitute in sterile bacteriostatic water. Typical stock concentration: 2 mg/mL. |
Every order of PT-141 includes a batch-specific CoA with HPLC chromatogram, mass spectrometry data, and laboratory accreditation details.
PT-141 (Bremelanotide) is a synthetic cyclic melanocortin receptor agonist investigated in research for its activity at MC3R/MC4R and association with arousal-related signalling.
99%+, confirmed by independent third-party HPLC analysis. Batch-specific CoA included.
No. Supplied for in vitro laboratory research only. Not a licensed medicine.
PT-141 is supplied by Premio Peptides (BELL RED LIMITED) exclusively for in vitro laboratory research. It is not a licensed medicine, is not approved for human or veterinary use, and must not be administered to any living organism outside a formally approved research protocol. Purchasers assume full responsibility for compliance with applicable regulations.